TENAX THERAPEUTICS, INC. (TENX) Free cash flow 2016–2022
TENAX THERAPEUTICS, INC. (TENX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.4MFY2022 · since FY2016: -$15.9M → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$11.4M | -4.9% |
| FY2021 | -$10.9M | -17.1% |
| FY2020 | -$9.3M | -22.7% |
| FY2019 | -$7.6M | -37.3% |
| FY2018 | -$5.5M | +54.7% |
| FY2017 | -$12.1M | +23.5% |
| FY2016 | -$15.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice